Professional continuous glucose monitoring in patients with diabetes mellitus: a systematic review and meta‐analysis
Di Molfetta S, Caruso I, Cignarelli A, et al.
Diabetes Obes Metab. Pub. online 20 Jan 2023.
Leggi
GLP-1 receptor agonists and the risk of thyroid cancer
Bezin J, Gouverneur A, Pénichon M, et al.
Diabetes Care. 2023;46(2):384-90
Leggi
Individual or familial diabetes in relation to eight cardiovascular diseases: a two-sample mendelian randomization study
Hu MJ, Hu S, Tan JS, Yang YJ
NMCD. Pub. online 29 Jan 2023.
Leggi
Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the US
Valentine WJ, Hoog M, Mody R, et al.
Diabetes Obes Metab. Pub. online 18 Jan 2023.
Leggi
Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England
Ling S, Zaccardi F, Issa E, et al.
Diabetologia. Pub. online 24 Jan 2023.
Leggi
Pharmacokinetics and pharmacodynamics of a novel u500 insulin aspart formulation: a randomized, double-blind, crossover study in people with type 1 diabetes
Svehlikova E, Ashcroft NL, Gatschelhofer C, et al.
Diabetes Care. 2023;dc221054.
Leggi
Do sex differences in paediatric type 1 diabetes care exist? A systematic review
de Vries SAG, Verheugt CL, Mul D, et al.
Diabetologia. Pub. online 26 Jan 2023.
Leggi
Sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies
Hinton W, Ansari AS, Whyte MB, et al.
Diabetes Obes Metab. 2023;25(2):501-515.
Leggi
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset
Carrera P, Marzinotto I, Bonfanti R, et al.
Diabetologia. Pub. online 24 Jan 2023.
Leggi
Comparison of cardiovascular mortality between MAFLD and NAFLD: a cohort study
Yoo TK, Lee MY, Kim SH, et al.
NMCD. Pub. Online 24 Jan 2023.
Leggi